CLINICAL_TRIALS
trial_result
· 2018-01-04
Clinical Trial Update: 24-hr Intraocular Pressure Control With SIMBRINZA ® [Phase 4]
Summary
Phase 4 clinical trial evaluating 24-hour intraocular pressure control with SIMBRINZA in glaucoma; results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Alcon Research | Conditions: Glaucoma | Phase 4 | Status: COMPLETED | Results posted: 2018-01-04